PuSH - Publication Server of Helmholtz Zentrum München

Pokhrel, S.* ; Evers, S.* ; Leidl, R. ; Trapero-Bertran, M.* ; Kalo, Z.* ; Vries, H.d.* ; Crossfield, A.* ; Andrews, F.* ; Rutter, A.* ; Coyle, K.* ; Lester-George, A.* ; West, R.* ; Owen, L.* ; Jones, T.* ; Vogl, M. ; Radu-Loghin, C.* ; Voko, Z.* ; Huic, M.* ; Coyle, D.*

EQUIPT: Protocol of a comparative effectiveness research study evaluating cross-context transferability of economic evidence on tobacco control.

BMJ Open 4:e006945 (2014)
Publ. Version/Full Text DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
INTRODUCTION: Tobacco smoking claims 700 000 lives every year in Europe and the cost of tobacco smoking in the EU is estimated between €98 and €130 billion annually; direct medical care costs and indirect costs such as workday losses each represent half of this amount. Policymakers all across Europe are in need of bespoke information on the economic and wider returns of investing in evidence-based tobacco control, including smoking cessation agendas. EQUIPT is designed to test the transferability of one such economic evidence base-the English Tobacco Return on Investment (ROI) tool-to other EU member states. METHODS AND ANALYSIS: EQUIPT is a multicentre, interdisciplinary comparative effectiveness research study in public health. The Tobacco ROI tool already developed in England by the National Institute for Health and Care Excellence (NICE) will be adapted to meet the needs of European decision-makers, following transferability criteria. Stakeholders' needs and intention to use ROI tools in sample countries (Germany, Hungary, Spain and the Netherlands) will be analysed through interviews and surveys and complemented by secondary analysis of the contextual and other factors. Informed by this contextual analysis, the next phase will develop country-specific ROI tools in sample countries using a mix of economic modelling and Visual Basic programming. The results from the country-specific ROI models will then be compared to derive policy proposals that are transferable to other EU states, from which a centralised web tool will be developed. This will then be made available to stakeholders to cater for different decision-making contexts across Europe. ETHICS AND DISSEMINATION: The Brunel University Ethics Committee and relevant authorities in each of the participating countries approved the protocol. EQUIPT has a dedicated work package on dissemination, focusing on stakeholders' communication needs. Results will be disseminated via peer-reviewed publications, e-learning resources and policy briefs.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
2.063
1.125
27
29
Tags
Annotations
Special Publikation
Hide on homepage

Edit extra information
Edit own tags
Private
Edit own annotation
Private
Hide on publication lists
on hompage
Mark as special
publikation
Publication type Article: Journal article
Document type Scientific Article
Keywords Cost-effectiveness ; Return On Investment ; Smoking Cessation ; Tobacco
Language english
Publication Year 2014
HGF-reported in Year 2014
ISSN (print) / ISBN 2044-6055
e-ISSN 2044-6055
Journal BMJ Open
Quellenangaben Volume: 4, Issue: 11, Pages: , Article Number: e006945 Supplement: ,
Publisher BMJ Publishing Group
Reviewing status Peer reviewed
Institute(s) Institute of Health Economics and Health Care Management (IGM)
German Center for Lung Research (DZL)
POF-Topic(s) 30202 - Environmental Health
80000 - German Center for Lung Research
Research field(s) Genetics and Epidemiology
PSP Element(s) G-505300-001
G-501800-531
PubMed ID 25421342
Scopus ID 84912035793
Erfassungsdatum 2014-11-27